Regulation and Views on Drug Clinical Trials in China - Apec-ahc.org

More documents

Recommendations

Info

China’s strength for MRCT 18 Talents Cost Market � 。 Resource STATE FOOD AND DRUG ADMINISTRATION
Challenges 19 Approval timeline Import <strong>and</strong> export of samples ADR reporting IPR Lack of institutions Infrastructure & personnel Incentive policy STATE FOOD AND DRUG ADMINISTRATION
Page 1 and 2: Regulation <strong
Page 3 and 4: Approval of drug clinical trials 3
Page 5 and 6: Drug Administration Law � Article
Page 7 and 8: Different clinical trials �clinic
Page 9 and 10: Requirement for sponsors •qualifi
Page 11 and 12: Highlights of regulation on trials
Page 13 and 14: 13 new chemical compounds,1 new TCM
Page 15 and 16: 15 CDE � Highly professional team
Page 17: 17 MRCT � Main sponsors: big inte
Page 21 and 22: 21 MRCT in China: 2002 - 2008 STATE
Page 23 and 24: Risk-benefit Analysis � Benefits
Page 25 and 26: 25 GCP Implementation STATE FOOD AN
Page 27 and 28: Accreditation by Jun. 1, 23 Notice
Page 29 and 30: 29 Clinical trial institutions abou
Page 31 and 32: 31 Clinical trial institutions Appr
Page 33 and 34: Comparison between China an
Page 35 and 36: Inspections � Supervisory inspect
Page 37 and 38: 1. improve legal and</stron
Page 39 and 40: Innovative drugs � While focusing
Page 41 and 42: Targets 41 set up a team of GCP ins
Page 43: 43 Thank you! STATE FOOD AND DRUG A

Regulation and Views on Drug Clinical Trials in China - Apec-ahc.org

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?